Amniocentesis performed at 14 weeks' gestation or earlier

Comparison with first-trimester transabdominal chorionic villus sampling

L. P. Shulman, S. Elias, Owen Phillips, C. Grevengood, J. S. Dungan, J. L. Simpson

Research output: Contribution to journalArticle

25 Citations (Scopus)

Abstract

Objective: To compare our initial experiences with early amniocentesis and transabdominal chorionic villus sampling (CVS). Methods: We compared the diagnostic and pregnancy outcomes of our initial 250 patients undergoing early amniocentesis (at or before the 14th completed week of gestation) or transabdominal CVS (performed between 9.5-12.9 weeks' gestation). In both groups, the indication for prenatal diagnosis was advanced maternal age (35 years or older at estimated date of delivery). Results: No diagnostic errors were made using either technique, and the culture failure rate for both methods was 0.8% (two of 250). Seven cytogenetic abnormalities in the early amniocentesis group and seven in the transabdominal CVS group were detected. Nine of the 250 women undergoing early amniocentesis reported spontaneous miscarriages following the procedure, compared to five in the transabdominal CVS group. The loss rates were 3.8% in the early amniocentesis group and 2.1% in the transabdominal CVS group among continuing pregnancies. Frequencies of premature delivery, small for gestational age infants, and associated structural defects in both groups were comparable. Conclusions: At this time, early amniocentesis cannot be assumed to be equal to conventional transabdominal CVS or amniocentesis with regard to safety or accuracy; only a large cohort randomized study will adequately determine the safety and efficacy of early amniocentesis.

Original languageEnglish (US)
Pages (from-to)543-548
Number of pages6
JournalObstetrics and gynecology
Volume83
Issue number4
DOIs
StatePublished - Jan 1 1994

Fingerprint

Chorionic Villi Sampling
Amniocentesis
First Pregnancy Trimester
Pregnancy
Small for Gestational Age Infant
Safety
Culture Techniques
Maternal Age
Spontaneous Abortion
Pregnancy Outcome
Diagnostic Errors
Prenatal Diagnosis
Chromosome Aberrations
Cohort Studies

All Science Journal Classification (ASJC) codes

  • Obstetrics and Gynecology

Cite this

Amniocentesis performed at 14 weeks' gestation or earlier : Comparison with first-trimester transabdominal chorionic villus sampling. / Shulman, L. P.; Elias, S.; Phillips, Owen; Grevengood, C.; Dungan, J. S.; Simpson, J. L.

In: Obstetrics and gynecology, Vol. 83, No. 4, 01.01.1994, p. 543-548.

Research output: Contribution to journalArticle

Shulman, L. P. ; Elias, S. ; Phillips, Owen ; Grevengood, C. ; Dungan, J. S. ; Simpson, J. L. / Amniocentesis performed at 14 weeks' gestation or earlier : Comparison with first-trimester transabdominal chorionic villus sampling. In: Obstetrics and gynecology. 1994 ; Vol. 83, No. 4. pp. 543-548.
@article{ffd7df3da85c4702953748cc607f89ab,
title = "Amniocentesis performed at 14 weeks' gestation or earlier: Comparison with first-trimester transabdominal chorionic villus sampling",
abstract = "Objective: To compare our initial experiences with early amniocentesis and transabdominal chorionic villus sampling (CVS). Methods: We compared the diagnostic and pregnancy outcomes of our initial 250 patients undergoing early amniocentesis (at or before the 14th completed week of gestation) or transabdominal CVS (performed between 9.5-12.9 weeks' gestation). In both groups, the indication for prenatal diagnosis was advanced maternal age (35 years or older at estimated date of delivery). Results: No diagnostic errors were made using either technique, and the culture failure rate for both methods was 0.8{\%} (two of 250). Seven cytogenetic abnormalities in the early amniocentesis group and seven in the transabdominal CVS group were detected. Nine of the 250 women undergoing early amniocentesis reported spontaneous miscarriages following the procedure, compared to five in the transabdominal CVS group. The loss rates were 3.8{\%} in the early amniocentesis group and 2.1{\%} in the transabdominal CVS group among continuing pregnancies. Frequencies of premature delivery, small for gestational age infants, and associated structural defects in both groups were comparable. Conclusions: At this time, early amniocentesis cannot be assumed to be equal to conventional transabdominal CVS or amniocentesis with regard to safety or accuracy; only a large cohort randomized study will adequately determine the safety and efficacy of early amniocentesis.",
author = "Shulman, {L. P.} and S. Elias and Owen Phillips and C. Grevengood and Dungan, {J. S.} and Simpson, {J. L.}",
year = "1994",
month = "1",
day = "1",
doi = "10.1097/00006250-199404000-00010",
language = "English (US)",
volume = "83",
pages = "543--548",
journal = "Obstetrics and Gynecology",
issn = "0029-7844",
publisher = "Lippincott Williams and Wilkins",
number = "4",

}

TY - JOUR

T1 - Amniocentesis performed at 14 weeks' gestation or earlier

T2 - Comparison with first-trimester transabdominal chorionic villus sampling

AU - Shulman, L. P.

AU - Elias, S.

AU - Phillips, Owen

AU - Grevengood, C.

AU - Dungan, J. S.

AU - Simpson, J. L.

PY - 1994/1/1

Y1 - 1994/1/1

N2 - Objective: To compare our initial experiences with early amniocentesis and transabdominal chorionic villus sampling (CVS). Methods: We compared the diagnostic and pregnancy outcomes of our initial 250 patients undergoing early amniocentesis (at or before the 14th completed week of gestation) or transabdominal CVS (performed between 9.5-12.9 weeks' gestation). In both groups, the indication for prenatal diagnosis was advanced maternal age (35 years or older at estimated date of delivery). Results: No diagnostic errors were made using either technique, and the culture failure rate for both methods was 0.8% (two of 250). Seven cytogenetic abnormalities in the early amniocentesis group and seven in the transabdominal CVS group were detected. Nine of the 250 women undergoing early amniocentesis reported spontaneous miscarriages following the procedure, compared to five in the transabdominal CVS group. The loss rates were 3.8% in the early amniocentesis group and 2.1% in the transabdominal CVS group among continuing pregnancies. Frequencies of premature delivery, small for gestational age infants, and associated structural defects in both groups were comparable. Conclusions: At this time, early amniocentesis cannot be assumed to be equal to conventional transabdominal CVS or amniocentesis with regard to safety or accuracy; only a large cohort randomized study will adequately determine the safety and efficacy of early amniocentesis.

AB - Objective: To compare our initial experiences with early amniocentesis and transabdominal chorionic villus sampling (CVS). Methods: We compared the diagnostic and pregnancy outcomes of our initial 250 patients undergoing early amniocentesis (at or before the 14th completed week of gestation) or transabdominal CVS (performed between 9.5-12.9 weeks' gestation). In both groups, the indication for prenatal diagnosis was advanced maternal age (35 years or older at estimated date of delivery). Results: No diagnostic errors were made using either technique, and the culture failure rate for both methods was 0.8% (two of 250). Seven cytogenetic abnormalities in the early amniocentesis group and seven in the transabdominal CVS group were detected. Nine of the 250 women undergoing early amniocentesis reported spontaneous miscarriages following the procedure, compared to five in the transabdominal CVS group. The loss rates were 3.8% in the early amniocentesis group and 2.1% in the transabdominal CVS group among continuing pregnancies. Frequencies of premature delivery, small for gestational age infants, and associated structural defects in both groups were comparable. Conclusions: At this time, early amniocentesis cannot be assumed to be equal to conventional transabdominal CVS or amniocentesis with regard to safety or accuracy; only a large cohort randomized study will adequately determine the safety and efficacy of early amniocentesis.

UR - http://www.scopus.com/inward/record.url?scp=0028300682&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028300682&partnerID=8YFLogxK

U2 - 10.1097/00006250-199404000-00010

DO - 10.1097/00006250-199404000-00010

M3 - Article

VL - 83

SP - 543

EP - 548

JO - Obstetrics and Gynecology

JF - Obstetrics and Gynecology

SN - 0029-7844

IS - 4

ER -